- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Study: Qingpeng ointment reduces pain, swelling and improves joint mobility
A recent study delved into the efficacy and safety of a traditional Tibetan medicine the Qingpeng ointment (QPO), in managing acute gouty arthritis (AGA) symptoms. The findings were published in BMC Complementary Medicine and Therapies.
This study employed a rigorous randomized, double-blind, placebo-controlled trial design and involved the individuals with AGA whose joint pain rated at least 3 on a visual analog scale (VAS) from 0 to 10. The participants were randomly assigned to receive either QPO application twice daily for seven consecutive days or a placebo. Joint pain and swelling were the primary outcomes assessed, while the secondary outcomes included joint mobility, redness, serum uric acid levels, C-reactive protein levels and the amount of remaining rescue medicine. And any adverse events were meticulously recorded throughout the trial.
The results from this study revealed compelling evidence of the effectiveness of QPO in managing AGA symptoms. The participants in the QPO group underwent significant reduction in joint pain and swelling when compared to the individuals in the placebo group. Also, QPO demonstrated a clear improvement in joint mobility which is a crucial aspect of AGA management.
This study also emphasized the safety profile of QPO, where only mild adverse events and primarily skin irritation were reported, these were resolved with dosage adjustment or discontinuation of the medication. Traditional medicines like the QPO are deeply rooted in centuries-old practices which helps in exploring novel therapeutic interventions for AGA and other inflammatory conditions.
Source:
Shang, Y., Wei, S., Yang, K., Liu, Y., Wei, S., Dong, X., Wang, X., Xie, Z., Fang, R., Liang, L., Li, X., Xu, L., Chen, M., Zhang, K., Huang, J., Wang, L., Yang, Y., Liao, H., Xing, G., … Liu, J. (2024). Efficacy of Qingpeng ointment (a Tibetan medicine) for acute gouty arthritis: a multi-center, randomized, double-blind, placebo-controlled trial. In BMC Complementary Medicine and Therapies (Vol. 24, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1186/s12906-023-04328-7
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751